These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31423707)

  • 1. Successful management of acute bilirubin encephalopathy in a dog with immune-mediated hemolytic anemia using therapeutic plasma exchange.
    Heffner GG; Cavanagh A; Nolan B
    J Vet Emerg Crit Care (San Antonio); 2019 Sep; 29(5):549-557. PubMed ID: 31423707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of therapeutic plasma exchange to reduce serum bilirubin in a dog with kernicterus.
    Tovar T; Deitschel S; Guenther C
    J Vet Emerg Crit Care (San Antonio); 2017 Jul; 27(4):458-464. PubMed ID: 28605161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of therapeutic plasma exchange on serum immunoglobulin concentrations in a dog with refractory immune-mediated hemolytic anemia.
    Scagnelli AM; Walton SA; Liu CC; Acierno MJ
    J Am Vet Med Assoc; 2018 May; 252(9):1108-1112. PubMed ID: 29641335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrifugal therapeutic plasma exchange in dogs with immune-mediated hemolytic anemia (2016-2018): 7 cases.
    Culler CA; Vigani A; Ripoll AZ; Gareau A; Suter SE
    J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):645-652. PubMed ID: 35499963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange for the management of a type III hypersensitivity reaction and suspected immune-mediated vasculitis assumed to be caused by human albumin administration in a dog.
    Klainbart S; Segev G; Kelmer E; Chen H
    J Vet Emerg Crit Care (San Antonio); 2022 Jul; 32(4):532-538. PubMed ID: 35234339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of clinical signs associated with hepatic encephalopathy with manual therapeutic plasma exchange in a dog.
    Culler CA; Reinhardt A; Vigani A
    J Vet Emerg Crit Care (San Antonio); 2020 May; 30(3):312-317. PubMed ID: 32077185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs.
    Francey T; Etter M; Schweighauser A
    J Vet Intern Med; 2021 Mar; 35(2):925-935. PubMed ID: 33571376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of therapeutic plasmapheresis in a case of canine immune-mediated hemolytic anemia.
    Crump KL; Seshadri R
    J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):375-80. PubMed ID: 25164638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption in a dog with severe immune mediated hemolytic anemia.
    Richter P; Fischer H; Dörfelt R
    J Clin Apher; 2021 Aug; 36(4):668-672. PubMed ID: 34033686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C
    Goggs R; Behling-Kelly E
    BMC Vet Res; 2019 Dec; 15(1):475. PubMed ID: 31888626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.
    Goggs R; Dennis SG; Di Bella A; Humm KR; McLauchlan G; Mooney C; Ridyard A; Tappin S; Walker D; Warman S; Whitley NT; Brodbelt DC; Chan DL
    J Vet Intern Med; 2015; 29(6):1603-10. PubMed ID: 26473338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990).
    Klag AR; Giger U; Shofer FS
    J Am Vet Med Assoc; 1993 Mar; 202(5):783-8. PubMed ID: 8454517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia.
    Zoia A; Gerou-Ferriani M; Drigo M; Caldin M
    J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia.
    Bestwick JP; Sharman M; Whitley NT; Kisielewicz C; Skelly BJ; Tappin S; Kellett-Gregory L; Seth M
    J Vet Intern Med; 2022 Jan; 36(1):78-85. PubMed ID: 34779044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia.
    Goggs R
    Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1327-1349. PubMed ID: 32814628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of carprofen overdose with therapeutic plasma exchange in a dog.
    Kjaergaard AB; Davis JL; Acierno MJ
    J Vet Emerg Crit Care (San Antonio); 2018 Jul; 28(4):356-360. PubMed ID: 29898245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
    Horgan JE; Roberts BK; Schermerhorn T
    J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ibuprofen intoxication in a dog via therapeutic plasma exchange.
    Walton S; Ryan KA; Davis JL; Acierno M
    J Vet Emerg Crit Care (San Antonio); 2017 Jul; 27(4):451-457. PubMed ID: 28481451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.